Loading...

 23-Feb-18, Deal Street Asia 

Hong Kong-listed medical device manufacturer MicroPort Scientific Corporation and Chinese PE firm Yunfeng Capital will acquire the cardiac rhythm management business of US-listed medical technology company LinaNova for USD190 mn in cash.

MicroPort partners Chinas Yunfeng to buy LivaNova (c) Deal Street Asia

Image: Deal Street Asia

MicroPort will contribute 75 per cent, while Yunfeng Capital will provide the remaining 25 per cent.

The companies will acquire a business franchise that develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failures.

 Read the full article  

 Healthcare insights 

Share